Tissue plasminogen activator in the treatment of superior vena caval thrombosis associated with parenteral nutrition

G R Barclay; K Allen; C R Pennington

doi:10.1136/pgmj.66.775.398

Tissue plasminogen activator in the treatment of superior vena caval thrombosis associated with parenteral nutrition

Postgrad Med J. 1990 May;66(775):398-400. doi: 10.1136/pgmj.66.775.398.

Authors

G R Barclay¹, K Allen, C R Pennington

Affiliation

¹ Department of Medicine, Ninewells Hospital and Medical School, Dundee, UK.

Abstract

Two patients, one of whom was pregnant, developed superior vena caval thrombosis while receiving central parenteral nutrition. They were successfully treated with recombinant tissue plasminogen activator (t-PA).

Publication types

Case Reports

MeSH terms

Adult
Aged
Aged, 80 and over
Female
Humans
Male
Parenteral Nutrition, Total / adverse effects*
Pregnancy
Pregnancy Complications, Cardiovascular / drug therapy
Pregnancy Complications, Cardiovascular / etiology*
Thrombosis / drug therapy
Thrombosis / etiology*
Tissue Plasminogen Activator / therapeutic use*
Vena Cava, Superior

Substances

Tissue Plasminogen Activator